Business Description
Genor Biopharma Holdings Ltd
ISIN : KYG3871A1004
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 162.89 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 55.2 | |||||
3-Year EPS without NRI Growth Rate | 53.9 | |||||
3-Year FCF Growth Rate | 40.1 | |||||
3-Year Book Growth Rate | -30.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.38 | |||||
9-Day RSI | 68.54 | |||||
14-Day RSI | 63.85 | |||||
6-1 Month Momentum % | 17.09 | |||||
12-1 Month Momentum % | 42.71 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.41 | |||||
Quick Ratio | 5.38 | |||||
Cash Ratio | 5.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | 3.03 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -44.05 | |||||
ROA % | -37.18 | |||||
ROIC % | -184.44 | |||||
3-Year ROIIC % | -91.05 | |||||
ROC (Joel Greenblatt) % | -437.83 | |||||
ROCE % | -42.95 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.64 | |||||
Price-to-Tangible-Book | 0.7 | |||||
EV-to-EBIT | 0.58 | |||||
EV-to-EBITDA | 0.58 | |||||
EV-to-FCF | 0.92 | |||||
Price-to-Net-Current-Asset-Value | 0.77 | |||||
Price-to-Net-Cash | 0.85 | |||||
Earnings Yield (Greenblatt) % | 172.41 | |||||
FCF Yield % | -54.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Genor Biopharma Holdings Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.171 | ||
Beta | 0.43 | ||
Volatility % | 83.84 | ||
14-Day RSI | 63.85 | ||
14-Day ATR (€) | 0.003425 | ||
20-Day SMA (€) | 0.16065 | ||
12-1 Month Momentum % | 42.71 | ||
52-Week Range (€) | 0.0845 - 0.169 | ||
Shares Outstanding (Mil) | 516.19 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Genor Biopharma Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Genor Biopharma Holdings Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Genor Biopharma Holdings Ltd Frequently Asked Questions
What is Genor Biopharma Holdings Ltd(FRA:67N0)'s stock price today?
When is next earnings date of Genor Biopharma Holdings Ltd(FRA:67N0)?
Does Genor Biopharma Holdings Ltd(FRA:67N0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |